Laurel Wealth Advisors (North Carolina)’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-70
Closed -$1.74K 749
2024
Q2
$1.74K Hold
70
﹤0.01% 558
2024
Q1
$2.32K Hold
70
﹤0.01% 539
2023
Q4
$2.49K Hold
70
﹤0.01% 502
2023
Q3
$2.39K Hold
70
﹤0.01% 505
2023
Q2
$2.8K Hold
70
﹤0.01% 495
2023
Q1
$2.75K Hold
70
﹤0.01% 495
2022
Q4
$2.23K Hold
70
﹤0.01% 481
2022
Q3
$2K Hold
70
﹤0.01% 497
2022
Q2
$3K Hold
70
﹤0.01% 516
2022
Q1
$3K Hold
70
﹤0.01% 564
2021
Q4
$4K Hold
70
﹤0.01% 518
2021
Q3
$4K Hold
70
﹤0.01% 523
2021
Q2
$4K Hold
70
﹤0.01% 584
2021
Q1
$4K Hold
70
﹤0.01% 541
2020
Q4
$4K Hold
70
﹤0.01% 506
2020
Q3
$3K Hold
70
﹤0.01% 471
2020
Q2
$3K Hold
70
﹤0.01% 462
2020
Q1
$3K Hold
70
﹤0.01% 455
2019
Q4
$4K Hold
70
﹤0.01% 464
2019
Q3
$4K Hold
70
﹤0.01% 447
2019
Q2
$4K Hold
70
﹤0.01% 455
2019
Q1
$3K Hold
70
﹤0.01% 446
2018
Q4
$3K Buy
+70
New +$2.55K ﹤0.01% 448

Other funds holding XRAY

Laurel Wealth Advisors (North Carolina)'s XRAY Position: Q3 2024 in Review

Laurel Wealth Advisors (North Carolina) sold out of Dentsply Sirona (XRAY) in Q3 2024, closing a stake of 70 shares — an estimated $1.74K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in XRAY in Q4 2018 and held it in 23 quarters. The position peaked at $4K in Q4 2021. 385 funds tracked by Wall St. Rank hold XRAY as of Q3 2024.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Dentsply Sirona position as of Q3 2024 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 70 Dentsply Sirona shares in Q3 2024, an estimated $1.74K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Dentsply Sirona in Q4 2018 and held it in 23 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Dentsply Sirona position peaked at $4K in Q4 2021.
  • 385 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2024.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2024, filed 5 Nov 2024.